Inventaire - je vrienden en communities zijn je beste bibliotheek

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies.

auteur

Toshi A Furukawa

Andrea Cipriani

Anna Chaimani

Georgia Salanti

gepubliceerd in: The Lancet Psychiatry

publicatiedatum: 2016-10-07

belangrijk thema: placebo, literatuuronderzoek

Cites articles 29

Date

Titel

Auteurs

2016

Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis

Stefan Leucht, Andrea Cipriani, Georgia Salanti, Kiyomi Shinohara, Toshi A Furukawa, Anna Chaimani, John R. Geddes
2015-01-01

Sharing individual patient data from clinical trials

Jeffrey M. Drazen
2015-03-01

Placebo eff ects in psychiatry: mediators and moderators

Luana Colloca, Katja Weimer, Paul Enck
2015-09-30

Implications of a Biosignature Study of the Placebo Response in Major Depressive Disorder.
2015-10-01

Time to abandon placebo control in pivotal phase III trials?

Andrea Cipriani, John R. Geddes
2014-04-01

Demystifying fixed and random effects meta-analysis

Georgia Salanti
2014-01-13

Impact of patient selection and study characteristics on signal detection in placebo-controlled trials with antidepressants

Giulio Perugi
2014-06-25

Placebo for depression: we need to improve the quality of scientific information but also reject too simplistic approaches or ideological nihilism

Andrea Cipriani, John R. Geddes
2013-07-01

A model of placebo response in antidepressant clinical trials
2013-07-01

Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout
2013-01-15

Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis

Stefan Leucht, Andrea Cipriani, Georgia Salanti, Loukia M Spineli, Julian Higgins
2013-11-01

Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010.

Steven G Potkin, Shitij Kapur, Gary Remington, Ofer Agid, Eric Watsky, Douglas Vanderburg
2011-04-01

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications
2011-12-14

Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review

Juan Undurraga, Ross J Baldessarini
2011-06-01

Leveraging crowdsourcing to facilitate the discovery of new medicines

Aled Edwards, Stephen Friend, Thea Norman
2010-04-16

Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades?
2010-08-27

Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data

Hans-Jürgen Möller
2010-01-26

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses

Mark Sinyor, Krista L. Lanctot
2009-02-26

Meta-analysis of the placebo response in antidepressant trials

Yvonne Nestoriuc, Stefan G Hofmann, Winfried Rief
2008-12-01

Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder

Boris Birmaher
2008-09-26

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
2006-06-12

The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures

Augustus John Rush, M H Trivedi, Diane Warden
2006-11-01

Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram

Dan J. Stein
2005-01-01

Imputing response rates from means and standard deviations in meta-analyses

Toshi A Furukawa, Andrea Cipriani, Corrado Barbui, Norio Watanabe
2002-04-01

Placebo response in studies of major depression: variable, substantial, and growing
2002-09-16

Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports
2000-03-01

The impact of restrictive entry criterion during the placebo lead-in period.
1999-03-01

The failure of placebo-controlled studies. ECNP Consensus Meeting, September 13, 1997, Vienna. European College of Neuropsychopharmacology
1986-09

Meta-analysis in clinical trials

Nan Laird, Rebecca DerSimonian

Artike - wd:Q38802744

Welcome to Inventaire

de bibliotheek van je vrienden en communities

meer leren